Histone deacetylase inhibitor apicidin-mediated drug resistance: Involvement of P-glycoprotein

Yong Kee Kim(Catholic Kwandong University), Su‐Nam Kim(Korea Institute of Science and Technology), Hoi Young Lee(Konyang University), Wahn Soo Choi(Konkuk University), Jee Won Hwang(Sookmyung Women's University), Dong Wan Seo(Dankook University), Yong-Jin Song(Catholic Kwandong University), Nam Hyun Kim(Catholic Kwandong University), Jeung‐Whan Han(Sungkyunkwan University), Yeon-Suk Park
Biochemical and Biophysical Research Communications
February 13, 2008
10.1016/j.bbrc.2008.02.013
Cited by 33

Related Papers

TIMP-2 Mediated Inhibition of Angiogenesis
|Cell|2003|510
Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)
|Gut|2020|332
Autoimmune Chronic Pancreatitis
|The American Journal of Gastroenterology|2004|288
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
|PubMed|2000|279
Clinicopathologic review of 58 patients with biliary papillomatosis
|Cancer|2004|261